12
Participants
Start Date
August 31, 2011
Primary Completion Date
November 30, 2013
Study Completion Date
May 31, 2015
vacc. w/ Poly-ICLC & peptide-pulsed dendritic cells
Intradermal injection of 1x107 peptide-pulsed dendritic cells followed by intramuscular injection of 30 micrograms per kilogram Poly-ICLC on days 0, 14, 28 and 42. Additional dose of 30 micrograms per kilogram Poly-ICLC on days 3, 17, 31 and 45. Treatment given via one 56-day cycle. Leukapheresis performed at baseline for dendritic cell generation.
Medical University of South Carolina, Charleston
Collaborators (1)
Oncovir, Inc.
INDUSTRY
Carolyn Britten
OTHER